Bumetanide
- Generic Name
- Bumetanide
- Brand Names
- Bumex, Burinex
- Drug Type
- Small Molecule
- Chemical Formula
- C17H20N2O5S
- CAS Number
- 28395-03-1
- Unique Ingredient Identifier
- 0Y2S3XUQ5H
Overview
Bumetanide is a sulfamyl diuretic.
Background
Bumetanide is a sulfamyl diuretic.
Indication
For the treatment of edema associated with congestive heart failure, hepatic and renal disease including the nephrotic syndrome.
Associated Conditions
- Edema
Clinical Trials
FDA Approved Products
Bumetanide
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:1 mg in 1 1
Approved: 2018/09/05
NDC:50090-6345
Bumetanide
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:0.25 mg in 1 mL
Approved: 2023/04/07
NDC:0641-6008
Bumetanide
Manufacturer:Upsher-Smith Laboratories, LLC
Route:ORAL
Strength:2 mg in 1 1
Approved: 2018/10/12
NDC:0832-0542
Bumetanide
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:0.25 mg in 1 mL
Approved: 2023/04/07
NDC:0641-6007
Bumetanide
Manufacturer:AvPAK
Route:ORAL
Strength:1 mg in 1 1
Approved: 2023/10/17
NDC:50268-131
Singapore Approved Products
BURINEX TABLET 1 mg
Manufacturer:allphamed PHARBIL Arzneimittel GmbH
Form:TABLET
Strength:1 mg
Online:Yes
Approved: 1988/05/03
Approval:SIN00718P
BURINEX INJECTION 0.5 mg/ml
Manufacturer:CENEXI
Form:INJECTION
Strength:0.5 mg/ml
Online:Yes
Approved: 1988/05/20
Approval:SIN01421P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath